Additionally, the serum IL-10 and IL-12 levels in patients with HCC similarly surpassed those in control and non-malignant patients by up to 3.78- and 13.83-fold, respectively, arguing against the recently reported antitumor role of IL12 [17]. Here, IL10 is linked to hepatocellular carcinoma.